TENAX THERAPEUTICS, INC. (TENX) › Cost of RevenueTENAX THERAPEUTICS, INC. (TENX) — Cost of RevenueAnnual figures by period end, from SEC filings.2011-04-30: $219.2K2012-04-30: $51.3K2013-04-30: $43.1K2014-04-30: $129.8K2015-04-30: $02016-12-31: $0$02011-04-30Cost of Revenue (USD)2016-12-31Period endedCost of RevenueChange YoYSource filing2016-12-31$0—2017-03-16From 2016-01-012015-04-30$0-100.0%2017-03-16From 2014-05-012014-04-30$129.8K+201.1%2017-03-16From 2013-05-012013-04-30$43.1K-15.9%2014-07-29From 2012-05-012012-04-30$51.3K-76.6%2013-06-26From 2011-05-012011-04-30$219.2K—2012-07-25From 2010-05-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)